Literature DB >> 26204310

Quantitative Skeletal Muscle MRI: Part 2, MR Spectroscopy and T2 Relaxation Time Mapping-Comparison Between Boys With Duchenne Muscular Dystrophy and Healthy Boys.

Hee Kyung Kim1, Suraj Serai1, Diana Lindquist1, Arnold C Merrow1, Paul S Horn2,3, Dong Hoon Kim4, Brenda L Wong3.   

Abstract

OBJECTIVE: The purpose of this study is to validate the use of MR spectroscopy (MRS) in measuring muscular fat and to compare it with T2 maps in differentiating boys with Duchenne muscular dystrophy (DMD) from healthy boys. SUBJECTS AND METHODS: Forty-two boys with DMD and 31 healthy boys were evaluated with MRI with (1)H-MRS and T2 maps. Grading of muscle fat and edema on conventional images, calculation of fat fractions ([fat / fat] + water) on MRS, and calculation of T2 fat values on T2 maps of the gluteus maximus and vastus lateralis muscles were performed. Group comparisons were made. The 95% reference interval (RI) of fat fraction for the control group was applied and compared with T2 map results.
RESULTS: Minimal fat on T1-weighted images was seen in 90.3% (gluteus maximus) and 71.0% (vastus lateralis) of healthy boys, versus 33.3% (gluteus maximus) and 52.4% (vastus lateralis) of boys with DMD. Muscle edema was seen in none of the healthy boys versus 52.4% (gluteus maximus) and 57.1% (vastus lateralis) of the boys with DMD. Fat fractions were higher in the DMD group (52.7%, gluteus maximus; 27.3%, vastus lateralis) than in the control group (12.8%, gluteus maximus; 13.7%, vastus lateralis) (p < 0.001). The 95% RI for gluteus maximus (38.7%) resulted in 61.9% sensitivity and 100% specificity for differentiating boys with DMD from healthy boys, whereas the value for vastus lateralis (17.8%) resulted in 76.2% sensitivity and 100% specificity; both had lower accuracy than did T2 maps (100% sensitivity and specificity). There was a positive correlation between T2 fat values and fat fractions (p < 0.0001).
CONCLUSION: In differentiation of the two groups, T2 maps were more accurate than MRS. Fat fractions can underestimate the actual amount of fat because of coexisting muscle edema in DMD.

Entities:  

Keywords:  Duchenne muscular dystrophy; MR spectroscopy; MRI; T2 relaxation time mapping; skeletal muscle

Mesh:

Year:  2015        PMID: 26204310     DOI: 10.2214/AJR.14.13755

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  19 in total

Review 1.  Advanced MRI Techniques for Muscle Imaging.

Authors:  Vivek Kalia; Doris G Leung; Darryl B Sneag; Filippo Del Grande; John A Carrino
Journal:  Semin Musculoskelet Radiol       Date:  2017-08-03       Impact factor: 1.777

Review 2.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

Review 3.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

Review 4.  Quantitative MRI Musculoskeletal Techniques: An Update.

Authors:  Ricardo de Mello; Yajun Ma; Yang Ji; Jiang Du; Eric Y Chang
Journal:  AJR Am J Roentgenol       Date:  2019-04-17       Impact factor: 3.959

5.  Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.

Authors:  Sean M Lang; Tarek Alsaied; Philip R Khoury; Thomas D Ryan; Michael D Taylor
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-20       Impact factor: 2.357

6.  Modeling disease trajectory in Duchenne muscular dystrophy.

Authors:  William D Rooney; Yosef A Berlow; William T Triplett; Sean C Forbes; Rebecca J Willcocks; Dah-Jyuu Wang; Ishu Arpan; Harneet Arora; Claudia Senesac; Donovan J Lott; Gihan Tennekoon; Richard Finkel; Barry S Russman; Erika L Finanger; Saptarshi Chakraborty; Elliott O'Brien; Brendan Moloney; Alison Barnard; H Lee Sweeney; Michael J Daniels; Glenn A Walter; Krista Vandenborne
Journal:  Neurology       Date:  2020-03-17       Impact factor: 9.910

7.  MR biomarkers predict clinical function in Duchenne muscular dystrophy.

Authors:  Alison M Barnard; Rebecca J Willcocks; William T Triplett; Sean C Forbes; Michael J Daniels; Saptarshi Chakraborty; Donovan J Lott; Claudia R Senesac; Erika L Finanger; Ann T Harrington; Gihan Tennekoon; Harneet Arora; Dah-Jyuu Wang; H Lee Sweeney; William D Rooney; Glenn A Walter; Krista Vandenborne
Journal:  Neurology       Date:  2020-02-05       Impact factor: 9.910

8.  Multivoxel proton magnetic resonance spectroscopy in facioscapulohumeral muscular dystrophy.

Authors:  Doris G Leung; Xin Wang; Peter B Barker; John A Carrino; Kathryn R Wagner
Journal:  Muscle Nerve       Date:  2018-02-14       Impact factor: 3.852

9.  Skeletal Muscle Magnetic Resonance Biomarkers in GNE Myopathy.

Authors:  Chia-Ying Liu; Jianhua Yao; William C Kovacs; Joseph A Shrader; Galen Joe; Ronald Ouwerkerk; Ami K Mankodi; William A Gahl; Ronald M Summers; Nuria Carrillo
Journal:  Neurology       Date:  2020-11-20       Impact factor: 9.910

10.  Quantitative muscle MRI biomarkers in Duchenne muscular dystrophy: cross-sectional correlations with age and functional tests.

Authors:  Sarah P Sherlock; Yao Zhang; Michael Binks; Shannon Marraffino
Journal:  Biomark Med       Date:  2021-06-22       Impact factor: 2.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.